Rhabdomyosarcoma pediatric · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG ARST1431 Protocol B (VAC/VI and Temsirolimus) Partial | — | R 252 128 | 28d | — | — | — | — | — |
COG ARST0531 VAC/VI Arm | — | R 33 307 | — | — | — | — | — | — |
COG ARST0531 VAC Arm | — | R 27 592 | — | — | — | — | — | — |
COG ARST1431 Protocol A (VAC/VI Only) | — | R 175 | 28d | — | — | — | — | — |
4 of 4 regimens shown